documents: FDA-1999-D-0081-0051

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1999-D-0081-0051 FDA FDA-1999-D-0081 Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up; Guidance for Industry; Availability Notice Notice of Availability 2020-01-30T05:00:00Z 2020 1 2020-01-30T05:00:00Z   2020-01-30T15:00:54Z 2020-01700 0 0 090000648430aa3d

Links from other tables